Adrian Rawcliffe's Net Worth
Adrian Rawcliffe's net worth is estimated to be at least $1,440,392.43 as of 11/22/2024. CoreStreet's estimation of Adrian Rawcliffe's net worth is based on their sale of stock and current holding of stock.
Adrian Rawcliffe is CEO at Adaptimmune Therapeutics Plc. They have executed at least 23 trades of stock as per SEC Form 4 filings. Their most recent trade was for 9,304 units of ADAP stock on 01/16/2024. Their biggest sale was on 03/20/2018 when they sold 600,000 units of Adaptimmune Therapeutics Plc stock for $1,026,000.00. They typically trade 3 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $1,440,392.43
Most recent insider trade:
- Jan. 16, 2024
Adrian Rawcliffe's Insider Trading History
Adaptimmune Therapeutics Plc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Jan. 16, 2024 | CEO | 9,304 | $0.79 | Sell | $7,350.16 |
Jan. 11, 2024 | CEO | 11,945 | $0.84 | Sell | $10,033.80 |
Sept. 1, 2023 | CEO | 2,403 | $0.78 | Sell | $1,874.34 |
June 27, 2023 | CEO | 2,333 | $0.92 | Sell | $2,146.36 |
Jan. 17, 2023 | CEO | 10,057 | $1.86 | Sell | $18,706.02 |
Jan. 12, 2023 | CEO | 18,763 | $1.71 | Sell | $32,084.73 |
Jan. 4, 2023 | CEO | 5,073 | $1.69 | Sell | $8,573.37 |
Sept. 1, 2022 | CEO | 2,536 | $1.97 | Sell | $4,995.92 |
June 27, 2022 | CEO | 2,562 | $1.63 | Sell | $4,176.06 |
Jan. 18, 2022 | CEO | 11,096 | $3.19 | Sell | $35,396.24 |
Jan. 11, 2022 | CEO | 14,362 | $3.56 | Sell | $51,128.72 |
Jan. 4, 2022 | CEO | 5,532 | $4.06 | Sell | $22,459.92 |
Sept. 1, 2021 | CEO | 2,782 | $5.20 | Sell | $14,466.40 |
June 28, 2021 | CEO | 2,794 | $4.37 | Sell | $12,209.78 |
Jan. 19, 2021 | CEO | 9,879 | $5.67 | Sell | $56,013.93 |
Jan. 12, 2021 | CEO | 2,707 | $6.15 | Sell | $16,648.05 |
Jan. 4, 2021 | CEO | 4,967 | $5.33 | Sell | $26,474.11 |
Sept. 1, 2020 | CEO | 2,776 | $8.51 | Sell | $23,623.76 |
Aug. 3, 2020 | CEO | 2,788 | $9.25 | Sell | $25,789.00 |
Jan. 14, 2020 | CEO | 3,236 | $5.13 | Sell | $16,600.68 |
Jan. 6, 2020 | CEO | 5,900 | $1.20 | Sell | $7,080.00 |
Jan. 14, 2019 | CFO | 3,084 | $5.37 | Sell | $16,561.08 |
March 20, 2018 | CFO | 600,000 | $1.71 | Sell | $1,026,000.00 |